静脉对乙酰氨基酚涨价对儿童阑尾切除术后阿片类药物使用及结局的影响
该多中心回顾性队列研究纳入2011至2017年间美国46家儿童医院110,019例2至18岁健康阑尾切除术患儿,评估静脉对乙酰氨基酚涨价后其使用率及阿片类药物使用变化;结果显示静脉对乙酰氨基酚使用率从2011年3%升至2017年40.1%(P<.001),但涨价后增速减慢,术后阿片类药物使用率从73.6%降至58.6%(P<.001),且静脉对乙酰氨基酚组调整后药房费用更低。
要点
- 静脉对乙酰氨基酚使用率2011至2017年由3%升至40.1%,涨价后增速减慢。
- 术后阿片类药物使用率由2011年73.6%降至2017年58.6%。
- 静脉对乙酰氨基酚单用与阿片类单用的预测术后住院时间相似。
核心结论
- 儿童阑尾切除术后静脉对乙酰氨基酚使用率持续上升,但2014年涨价后增速显著减慢。
- 接受静脉对乙酰氨基酚的患儿调整后药房费用更低,可能继发于术后阿片类药物使用减少。
- 静脉对乙酰氨基酚单用与阿片类单用的预测术后住院时间相似。
研究设计与样本
- 多中心回顾性队列研究,使用儿科健康信息系统数据库2011至2017年数据。
- 纳入美国46家儿童医院2至18岁健康阑尾切除术患儿110,019例。
- 采用多变量混合效应模型分析术后阿片类使用、静脉对乙酰氨基酚使用与术后住院时间的关联。
主要发现
- 总体22.5%(N=24,777)患儿接受静脉对乙酰氨基酚。
- 静脉对乙酰氨基酚使用率从2011年3%升至2017年40.1%(P<.001),但涨价后增速显著减慢。
- 2014年后接受静脉对乙酰氨基酚的患儿调整后药房中位费用从$3,326.5(IQR $1,717.5-$6,710.8)降至$3,264.1(IQR $1,782.8-$5,934.7,P<.001)。
- 在94,745例术后住院≥1天的患儿中,术后阿片类药物使用率从2011年73.6%降至2017年58.6%(P<.001)。
- 静脉对乙酰氨基酚单用与阿片类单用相比,预测平均术后住院时间相似。
临床怎么用
- 临床可更广泛使用静脉对乙酰氨基酚以减少术后阿片类药物使用,而不必过度顾虑其费用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In 2014, the price of intravenous acetaminophen more than doubled. This study determined whether increased intravenous acetaminophen cost was associated with decreased utilization and increased opioid use for children undergoing appendectomy. METHODS: A multicenter retrospective cohort study using the Pediatric Health Information System database between 2011 and 2017 was performed. Healthy children 2 to 18 years undergoing appendectomy at 46 children's hospitals in the United States were identified. Intravenous acetaminophen use, opioid use, and pharmacy costs were assessed. Multivariable mixed-effects modeling was used to determine the association between postoperative opioid use, intravenous acetaminophen use, and postoperative length-of-stay. RESULTS: Overall, 110,019 children undergoing appendectomy were identified, with 22.5% (N = 24,777) receiving intravenous acetaminophen. Despite the 2014 price increase, intravenous acetaminophen use increased from 3% in 2011 to 40.1% in 2017 (P < .001), but at a significantly reduced rate. After 2014, adjusted median pharmacy charges decreased from $3,326.5 (interquartile range: $1,717.5-$6,710.8) to $3,264.1 (interquartile range: $1,782.8-$5,934.7, P < .001) for children who received intravenous acetaminophen. In 94,745 children staying ≥1 day after surgery, postoperative opioid use decreased from 73.6% in 2011 to 58.6% in 2017 (P < .001). Use of intravenous acetaminophen alone compared to opioids alone after surgery resulted in similar predicted mean postoperative length-of-stay. CONCLUSION: In children undergoing appendectomy, intravenous acetaminophen use continued to rise, but at a slower rate after a price increase. Furthermore, adjusted pharmacy charges were lower for children receiving intravenous acetaminophen, possibly secondary to a concurrent decrease in postoperative opioid use. These findings suggest intravenous acetaminophen may be more broadly used regardless of perceived costs to minimize opioid use after surgery.
引用
- Mahdi EM, Ourshalimian S, Darcy D, et al. The impact of intravenous acetaminophen pricing on opioid utilization and outcomes for children with appendicitis. Surgery. 2021. PMID: 33985768. doi:10.1016/j.surg.2021.04.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。